Bottom line
SHSSX vs GGHCX: the short answer
SHSSX (Blackrock Health Sciences Opportunities Portfolio) and GGHCX (INVESCO Health Care Fund) share a meaningful slice of their top holdings — about 57% by weight.
SHSSX is cheaper at 0.86% vs 1.07% — a difference of $21 a year per $10,000 invested.
Over five years, SHSSX returned +5.9% a year vs +2.6% for GGHCX.
GGHCX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
SHSSX vs GGHCX side by side
| SHSSX | GGHCX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BlackRock | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.86% | 1.07% |
| Annual cost per $10k | $86 | $107 |
| 10-yr cost on $10k (prospectus) | $1,061 | $1,784 |
| Max front load | 0% | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | +16.3% | +9.2% |
| 5-yr return (annualized) | +5.9% | +2.6% |
| 10-yr return (annualized) | +9.8% | +5.8% |
| Best quarter | — | +19.6% |
| Worst quarter | — | −16.5% |
| Net assets (fund) | $5.9B | $1.2B |
| Number of holdings | 155 | 82 |
| Portfolio turnover | 49% | 59% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of SHSSX's top 25 holdings also appear in GGHCX's top 25.
| Holding | SHSSX | GGHCX |
|---|---|---|
| Eli Lilly & Company | 12.29% | 10.59% |
| Johnson & Johnson | 8.77% | 6.76% |
| Unitedhealth Group Inc | 6.10% | 6.17% |
| Merck & Company Inc | 4.94% | 4.59% |
| Gilead Sciences Inc | 4.19% | 3.63% |
| Abbvie Inc | 3.94% | 4.03% |
| Thermo Fisher Scientific Inc | 3.02% | 1.55% |
| Vertex Pharmaceuticals Inc | 2.74% | 2.01% |
| Edwards Lifesciences Corp | 2.51% | 1.56% |
| Argenx Se | 1.26% | 3.24% |
Source: SEC Form N-PORT
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
FAQ
What is the difference between SHSSX and GGHCX?
Which is cheaper, SHSSX or GGHCX?
Should I own both SHSSX and GGHCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.